8/31/2023 0 Comments Thomas raskin covid![]() ![]() This virus is very good at sidestepping some of your immunity, but the kind of case that you're going to have if you've had particularly three shots is so much more likely to be a mild case of a couple of days of cold or flu symptoms than it would be for the unvaccinated person. There's no question that there are more breakthrough cases. The vaccines and boosters are miraculous, and they are miraculous because what they do is markedly lower the probability that you will get very sick, go to the hospital, go to the ICU, end up on a ventilator and die. Yeah, I can understand how people would feel that, but that's just not right. They don't work because everybody we know is getting sick anyway. The Coronavirus Crisis A pediatrician's advice to parents of kids under 5 on omicron, travel and day care People are also hearing that the vaccines and boosters aren't worth it. So it is taking the company some time to produce them, but the supply should grow steadily over the next couple of months. It's a pretty tricky chemical compound to produce. We have them in some of our pharmacies, but we're having to triage them quite severely and be very selective about who gets them, but I think they'll become more and more available over time. Can your high-risk patients get these COVID pills? You're the chair of medicine at a big hospital there in San Francisco. So that is another very important tool that we'll have. Within a month or two, there will be a decent supply. ![]() The Merck lowers the probability that someone who gets a case of omicron will land in the hospital by 30%, the Pfizer by 90%. The Pfizer is a much bigger deal than the Merck. ![]() Up till now, we've really just had monoclonal antibodies to give to people at very high risk who got COVID but were not sick enough yet to be in the hospital. Yeah, it's an important new part of our armamentarium. They're in small quantities so far, but what effect could these have in the coming weeks? And so we have a pretty miserable month, even though the average patient has a lower chance of ending up in the hospital than he or she would have had if they had a case of delta, particularly if they're vaccinated.Īntiviral COVID-19 pills are being rolled out. So the short-term risk - and we're seeing it all over the country - is the hospitals will get filled with patients with omicron.Ī fair number of doctors and nurses will be out sick with omicron. Why are the hospitals filling up? And the reason is, even if the average case is less likely to land you in the hospital, if there are twice or three or five times as many cases, then you will have more people laying in the hospital. Now you might hear that and say that doesn't make sense. So the average case of omicron has about a 60% lower chance of landing you in the hospital than the average case of delta. What we're not seeing is the same relationship between cases and hospitalizations. What's happening now is the cases are exploding, as we've never seen before, and that really is a manifestation of how extraordinarily infectious omicron is. Health These are the numbers health officials are watching at this point in the pandemic What are you seeing in terms of case rates and hospitalization rates, and what might you hope to see there in the coming weeks? ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |